A new study uncovered how the B. fragilis toxin damages colon tissue by binding to the receptor claudin-4, enabling the ...
A new study led by NYU Langone Health researchers found that cancer cells are better able to resist treatments when they have ...
Functional genomics is central to modern drug discovery, yet high attrition rates persist. In this article, Dr Salman ...
Hosted on MSN
New nanopillar film kills viruses without chemicals
Researchers have developed an acrylic film with nanopillars that physically rupture viruses on contact, eliminating the need for chemical disinfectants. Tested against human parainfluenza virus 3, the ...
Before you decide whether CRISPR Therapeutics stock looks attractive at around US$52.38, it helps to ask a simple question: what are you actually paying for compared with what the business might be ...
In this GEN webinar, Tilmann Buerckstuemmer, PhD, CSO at Myllia Biotechnology will show how high-throughput pooled CRISPR ...
High-content screening combines automated microscopy and quantitative image analysis to measure complex cellular phenotypes ...
What people see on screen can shape what they do off it. When actors such as James Dean and Marlon Brando lit cigarettes in ...
CRISPR Therapeutics stock snapshot and recent performance CRISPR Therapeutics (CRSP) has drawn investor attention after its recent trading, with the stock last closing at US$57.69 and posting a 0.5% ...
Background Over 90% pancreatic cancers harbour activating kirsten rat sarcoma viral oncogene homolog (KRAS）mutations. However, monotherapies targeting the KRAS vertical pathway, with recently ...
This article is based on a poster originally authored by Ce Zhong, Lu Bai, Tongtong Wang, Yiying Shao, Lingyun Zhang, Lu Zhang, and Jingqi Huang. CRISPR screens have successfully identified targetable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results